EUVIMEDEUVIMED entdecken
Leitlinie

Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines

Christina Wang, Maria Cristina Meriggiola, John K Amory, Christopher L R Barratt iD, Hermann M Behre, William J Bremner, Alberto Ferlin iD, Stanton Honig, Zsolt Kopa iD, Kirk Lo, Eberhard Nieschlag iD, Stephanie T Page und 5 weitere

Andrology · 2024-10 · 12 (7) · 1470-1500

DOI: 10.1111/andr.13525 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Andrology, online erschienen am 20.09.2023. Verfasst von Christina Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Medicine and Clinical and Translational Science Institute, The Lundquist Insitute and Harbor-UCLA Medical Ce…. Hauptthemen laut MEDLINE: Andrology, Contraception. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 190 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds Despite a wide spectrum of contraceptive methods for women, the unintended pregnancy rate remains high (45% in the US), with 50% resulting in abortion. Currently, 20% of global contraceptive use is male‐directed, with a wide variation among countries due to limited availability and lack of efficacy. Worldwide studies indicate that >50% of men would opt to use a reversible method, and 90% of women would rely on their partner to use a contraceptive. Additional reasons for novel male contraceptive methods to be available include the increased life expectancy, sharing the reproductive risks among partners, social issues, the lack of pharma industry involvement and the lack of opinion makers advocating for male contraception.

Aim

The present guidelines aim to review the status regarding male contraception, the current state of the art to support the clinical practice, recommend minimal requirements for new male contraceptive development and provide and grade updated, evidence‐based recommendations from the European Society of Andrology (EAA) and the American Society of Andrology (ASA).

Methods

An expert panel of academicians appointed by the EAA and the ASA generated a consensus guideline according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system.

Results

Sixty evidence‐based and graded recommendations were produced on couple‐centered communication, behaviors, barrier methods, semen analysis and contraceptive efficacy, physical agents, surgical methods, actions before initiating male contraception, hormonal methods, non‐hormonal methods, vaccines, and social and ethical considerations.

Conclusion

As gender roles transform and gender equity is established in relationships, the male contribution to family planning must be facilitated. Efficient and safe male‐directed methods must be evaluated and introduced into clinical practice, preferably reversible, either hormonal or non‐hormonal. From a future perspective, identifying new hormonal combinations, suitable testicular targets, and emerging vas occlusion methods will produce novel molecules and products for male contraception.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrologyContraceptionHumansMaleContraceptive Agents, MaleSocieties, MedicalUnited StatesFemaleEurope

Stichwörter der Autor:innen

barrier methodsbehaviorscontraceptive efficacycouple‐centerd communicationguidelineshormonal methodsmale contraceptionnon‐hormonal methodsphysical agentssemen analysissocial and ethical considerationssurgical methodsvaccines

Substanzen

Contraceptive Agents, Male

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Medicine and Clinical and Translational Science Institute, The Lundquist Insitute and Harbor-UCLA Medical Center, Torrance, California, USA.
  • Division of Gynecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Division of Systems and Cellular Medicine, Medical School, Ninewells Hospital, University of Dundee, Dundee, Scotland.
  • Center for Reproductive Medicine and Andrology, University Medicine Halle, Halle, Germany.
  • Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

ORCID-Profile: Christopher L R Barratt, Alberto Ferlin, Zsolt Kopa, Eberhard Nieschlag, Ronald S Swerdloff

Zitieren

APA

Wang, C., Meriggiola, M. C., Amory, J. K., Barratt, C. L. R., Behre, H. M., Bremner, W. J., Ferlin, A., Honig, S., Kopa, Z., Lo, K., Nieschlag, E., Page, S. T., Sandlow, J., Sitruk-Ware, R., Swerdloff, R. S., Wu, F. C. W., & Goulis, D. G. (2024). Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines. Andrology, 12(7), 1470-1500. https://doi.org/10.1111/andr.13525

Vancouver

Wang C, Meriggiola MC, Amory JK, Barratt CLR, Behre HM, Bremner WJ, et al. Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines. Andrology. 2024;12(7):1470-1500. doi:10.1111/andr.13525

BibTeX
@article{Wang2024,
  author = {Wang, Christina and Meriggiola, Maria Cristina and Amory, John K and Barratt, Christopher L R and Behre, Hermann M and Bremner, William J and Ferlin, Alberto and Honig, Stanton and Kopa, Zsolt and Lo, Kirk and Nieschlag, Eberhard and Page, Stephanie T and Sandlow, Jay and Sitruk-Ware, Regine and Swerdloff, Ronald S and Wu, Frederick C W and Goulis, Dimitrios G},
  title = {Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines},
  journal = {Andrology},
  year = {2024},
  volume = {12},
  number = {7},
  pages = {1470--1500},
  doi = {10.1111/andr.13525}
}
Kostenlos starten →